These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36897833)

  • 1. Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system.
    De la Cuadra-Grande A; Rioja-Zuazu J; Domínguez-Esteban M; Torres E; Blissett R; Woodward E; Oyagüez I; Fernández-Arjona M
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):499-510. PubMed ID: 36897833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
    Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
    J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.
    Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Fu S; Bhattacharyya SK; El-Arabi AM; Cutone BJ; McVary KT
    PLoS One; 2022; 17(4):e0266824. PubMed ID: 35427376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transurethral water vapor therapy for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a cost-minimization and budget impact analysis from an Italian healthcare perspective.
    Blissett RS; Blissett DB; Oselin M; Demaire C; Woodward E; Siciliano M; Torres E; Franzoso F; Comelli T
    Minerva Urol Nephrol; 2023 Jun; 75(3):343-352. PubMed ID: 36562138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.
    Sandhu JS; Bixler BR; Dahm P; Goueli R; Kirkby E; Stoffel JT; Wilt TJ
    J Urol; 2024 Jan; 211(1):11-19. PubMed ID: 37706750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy.
    Rojanasarot S; Cutone B; Durand K; Zorn KC; Chughtai B; Bhojani N; Elterman DS
    J Endourol; 2023 May; 37(5):575-580. PubMed ID: 36762936
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis.
    Franco JVA; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    BJU Int; 2022 Aug; 130(2):142-156. PubMed ID: 34820997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.
    Cornu JN; Zantek P; Burtt G; Martin C; Martin A; Springate C; Chughtai B
    Eur Urol; 2023 Jun; 83(6):534-547. PubMed ID: 36964042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Private Payer and Patient Out-of-Pocket Costs Associated With the Surgical Management of Benign Prostatic Hyperplasia.
    Wymer KM; Thao V; Narang G; Sharma V; Borah BJ; Cheney S; Humphreys MR
    Urology; 2024 Feb; 184():87-93. PubMed ID: 38065310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis.
    Li Z; Chen P; Wang J; Mao Q; Xiang H; Wang X; Wang X; Zhang X
    Medicine (Baltimore); 2016 Jun; 95(24):e3862. PubMed ID: 27310968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.
    Prudhomme T; Marquette T; Péré M; Patard PM; Michiels C; Sallusto F; Rigaud J; Glémain P; Kamar N; Blancho G; Soulié M; Rischmann P; Karam G; Gamé X; Robert G; Branchereau J
    J Endourol; 2020 Feb; 34(2):184-191. PubMed ID: 31588793
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia.
    Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Amorosi SL; Shore ND
    J Health Econ Outcomes Res; 2021 May; 8(1):42-50. PubMed ID: 33987450
    [No Abstract]   [Full Text] [Related]  

  • 14. Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis.
    Miller LE; Chughtai B; McVary K; Gonzalez RR; Rojanasarot S; DeRouen K; Bhattacharyya S
    Medicine (Baltimore); 2020 Jul; 99(30):e21365. PubMed ID: 32791742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.
    Sahakyan Y; Erman A; Bhojani N; Chughtai B; Zorn KC; Sander B; Elterman DS
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):113-118. PubMed ID: 35689083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?
    McVary KT; Rogers T; Mahon J; Gupta NK
    J Sex Med; 2018 Dec; 15(12):1728-1738. PubMed ID: 30446471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Kang TW; Jung JH; Hwang EC; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013251. PubMed ID: 32212174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.